142 related articles for article (PubMed ID: 28470097)
41. Sodium 4-phenylbutyrate protects against cerebral ischemic injury.
Qi X; Hosoi T; Okuma Y; Kaneko M; Nomura Y
Mol Pharmacol; 2004 Oct; 66(4):899-908. PubMed ID: 15226415
[TBL] [Abstract][Full Text] [Related]
42. Endoplasmic reticulum stress and insulin biosynthesis: a review.
Kim MK; Kim HS; Lee IK; Park KG
Exp Diabetes Res; 2012; 2012():509437. PubMed ID: 22474424
[TBL] [Abstract][Full Text] [Related]
43. Histone deacetylase inhibitors target diabetes via chromatin remodeling or as chemical chaperones?
Lawless MW; O'Byrne KJ; Gray SG
Curr Diabetes Rev; 2009 Aug; 5(3):201-9. PubMed ID: 19689255
[TBL] [Abstract][Full Text] [Related]
44. Pyrazinamide-induced hepatotoxicity is alleviated by 4-PBA via inhibition of the PERK-eIF2α-ATF4-CHOP pathway.
Guo HL; Hassan HM; Ding PP; Wang SJ; Chen X; Wang T; Sun LX; Zhang LY; Jiang ZZ
Toxicology; 2017 Mar; 378():65-75. PubMed ID: 28063906
[TBL] [Abstract][Full Text] [Related]
45. Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress.
Lombardi A; Tomer Y
J Autoimmun; 2017 Jun; 80():48-55. PubMed ID: 28238527
[TBL] [Abstract][Full Text] [Related]
46. Histone deacetylases in cardiovascular and metabolic diseases.
Bagchi RA; Weeks KL
J Mol Cell Cardiol; 2019 May; 130():151-159. PubMed ID: 30978343
[TBL] [Abstract][Full Text] [Related]
47. Identification of 1,2,3-triazole derivatives that protect pancreatic β cells against endoplasmic reticulum stress-mediated dysfunction and death through the inhibition of C/EBP-homologous protein expression.
Duan H; Arora D; Li Y; Setiadi H; Xu D; Lim HY; Wang W
Bioorg Med Chem; 2016 Jun; 24(12):2621-30. PubMed ID: 27157393
[TBL] [Abstract][Full Text] [Related]
48. Inside HDACs with more selective HDAC inhibitors.
Roche J; Bertrand P
Eur J Med Chem; 2016 Oct; 121():451-483. PubMed ID: 27318122
[TBL] [Abstract][Full Text] [Related]
49. A lipidomic screen of palmitate-treated MIN6 β-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking.
Boslem E; MacIntosh G; Preston AM; Bartley C; Busch AK; Fuller M; Laybutt DR; Meikle PJ; Biden TJ
Biochem J; 2011 Apr; 435(1):267-76. PubMed ID: 21265737
[TBL] [Abstract][Full Text] [Related]
50. HDAC inhibitors and chaperone function.
Rao R; Fiskus W; Ganguly S; Kambhampati S; Bhalla KN
Adv Cancer Res; 2012; 116():239-62. PubMed ID: 23088873
[TBL] [Abstract][Full Text] [Related]
51. Isoform-selective inhibitor of histone deacetylase 3 (HDAC3) limits pancreatic islet infiltration and protects female nonobese diabetic mice from diabetes.
Dirice E; Ng RWS; Martinez R; Hu J; Wagner FF; Holson EB; Wagner BK; Kulkarni RN
J Biol Chem; 2017 Oct; 292(43):17598-17608. PubMed ID: 28860191
[TBL] [Abstract][Full Text] [Related]
52. Development and therapeutic impact of HDAC6-selective inhibitors.
Dallavalle S; Pisano C; Zunino F
Biochem Pharmacol; 2012 Sep; 84(6):756-65. PubMed ID: 22728920
[TBL] [Abstract][Full Text] [Related]
53. Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms.
Brozzi F; Nardelli TR; Lopes M; Millard I; Barthson J; Igoillo-Esteve M; Grieco FA; Villate O; Oliveira JM; Casimir M; Bugliani M; Engin F; Hotamisligil GS; Marchetti P; Eizirik DL
Diabetologia; 2015 Oct; 58(10):2307-16. PubMed ID: 26099855
[TBL] [Abstract][Full Text] [Related]
54. Proinsulin misfolding and endoplasmic reticulum stress during the development and progression of diabetes.
Sun J; Cui J; He Q; Chen Z; Arvan P; Liu M
Mol Aspects Med; 2015 Apr; 42():105-18. PubMed ID: 25579745
[TBL] [Abstract][Full Text] [Related]
55. A novel hydroxysuberamide derivative potentiates MG132-mediated anticancer activity against human hormone refractory prostate cancers--the role of histone deacetylase and endoplasmic reticulum stress.
Chen YC; Huang WJ; Hsu JL; Yu CC; Wang WT; Guh JH
Prostate; 2013 Sep; 73(12):1270-80. PubMed ID: 23813634
[TBL] [Abstract][Full Text] [Related]
56. Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy.
Adhikari N; Jha T; Ghosh B
J Med Chem; 2021 Jul; 64(13):8827-8869. PubMed ID: 34161101
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic effects of histone deacetylase inhibitors on kidney disease.
Chun P
Arch Pharm Res; 2018 Feb; 41(2):162-183. PubMed ID: 29230688
[TBL] [Abstract][Full Text] [Related]
58. Is there any therapeutic value for the use of histone deacetylase inhibitors for chronic pain?
Wang W; Cui SS; Lu R; Zhang H
Brain Res Bull; 2016 Jul; 125():44-52. PubMed ID: 27090944
[TBL] [Abstract][Full Text] [Related]
59. Radioprotection by the histone deacetylase inhibitor phenylbutyrate.
Miller AC; Cohen S; Stewart M; Rivas R; Lison P
Radiat Environ Biophys; 2011 Nov; 50(4):585-96. PubMed ID: 21892632
[TBL] [Abstract][Full Text] [Related]
60. HDAC Inhibitors and RECK Modulate Endoplasmic Reticulum Stress in Tumor Cells.
Chen Y; Tsai YH; Tseng SH
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
